About Our Program

As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.

Featured Scientist

Richard M. Treger, MD
Richard M. Treger, MD
Clinician Investigator

Nephrology
Los Angeles

Dr. Richard Treger is a nephrologist and clinician researcher at the Kaiser Permanente Los Angeles Medical Center. He is interested in medical education and academic nephrology. He is a clinical associate professor and nephrology Phase 3 subspecialty director at the Kaiser Permanente Bernard J. Tyson School of Medicine. He is also the program director of the Kaiser Permanente Southern California Nephrology Fellowship program.

Dr. Treger has participated in multiple large clinical trials, ...

Featured Video

Advancing treatments through clinical trials

Over the years, clinical trials have led to amazing advances in treatment—even cures—for devastating illnesses. William Towner, MD, FACP, FIDSA, regional physician director for clinical trials, describes how trials at Kaiser Permanente contribute to the development of more effective and safer treatments for diseases such as HIV, hepatitis C, cancer, and more. (2:15)

News

Featured Image of News Story Titled: Tailored outreach may be needed for some young cancer survivors

Tailored outreach may be needed for some young cancer survivors

Growing numbers of patients are diagnosed with cancer between the ages of 15 and 39. These younger cancer patients can have complex health needs after their cancer treatment and should receive health care that includes screening for new cancers, addresses potential issues related to their treatment, and emphasizes general preventive care. Researchers at Kaiser Permanente ...

Researchers study young cancer survivors and their opioid use.

Young cancer survivors were more likely to be on long-term opioid therapy when compared to their counterparts without cancer. But among those on long-term opioid therapy, young cancer survivors were less likely to develop opioid use disorder than their peers without cancer, according to Kaiser Permanente research. The study was published in Cancer in May ...

Algorithm improves MS treatment while reducing disparities

A novel treatment algorithm developed and implemented within Kaiser Permanente Southern California increased the use of effective medications for people with multiple sclerosis (MS), and reduced treatment disparities for Hispanic and Black patients. “Studies show Hispanic and Black people with MS typically have higher levels of disability than white people, but no studies have addressed ...

Five questions for … Dr. Navdeep Sangha

Navdeep S. Sangha, MD, is a vascular neurologist and co-assistant chief of Neurology at the Kaiser Permanente Los Angeles Medical Center. He is the director of the Kaiser Permanente Southern California Regional Stroke Program and the Kaiser Permanente Southern California Telestroke Program. He joined Los Angeles Medical Center’s Neurology Department in 2012. As the principal investigator ...

Clinical trials nurse brings skill and compassion to patients in San Diego

*Final in a series highlighting research nurses during Nurses Week 2025* Michael Fechter, LVN, was an emergency medical technician, working to become a paramedic and firefighter. On one emergency call, a critical care transport nurse suggested something that changed the direction of his career. “She told me that I needed to be where I could ...

Events

Featured Division

Clinical Trials Research

Our physician investigators conduct clinical trials in communities across Southern California, from Bakersfield to San Diego.

The Division of Clinical Trials Research advances medical innovation by supporting evaluation of new drugs, therapies, and devices to prevent and treat health problems. Our physician investigators work with cooperative groups and industry sponsors to conduct clinical trials for investigational drugs, biologics, and devices. In addition, the division develops pragmatic trials that help answer questions about care delivery.

The region has clinical trials programs in oncology (adult, gynecologic, pediatric, and surgical/radiation oncology), urology, gynecology, neurology, dermatology, metabolic diseases, nephrology, ophthalmology, infectious disease, cardiology, hepatology, vascular surgery, and rheumatology. Clinical trials staff support trials at medical centers and medical office buildings throughout the Kaiser Permanente Southern California Region.